甲状腺癌或黑色素瘤个体中TINF2胚系截短突变导致端粒延长
对一个同时患甲状腺乳头状癌(PTC)和黑色素瘤的大家系进行基因组测序,发现 shelterin 基因 TINF2 存在移码突变(p.Trp198fs),该突变与两种肿瘤完全共分离,携带者相对端粒长度显著长于同家系非携带者及 62 名健康对照;在 24 个家系中 shelterin 基因编码变异罕见。
要点
- TINF2 p.Trp198fs 突变与家系中 PTC 和黑色素瘤完全共分离。
- 携带者相对端粒长度显著长于同家系非携带者及 62 名健康对照。
- 24 个家系中 shelterin 基因编码变异罕见,仅发现 3 个错义和 1 个同义变异。
核心结论
- TINF2 基因罕见移码突变及相关的端粒延长提示端粒调控异常可能是易感 PTC 和黑色素瘤的机制。
- shelterin 基因的 DNA 编码变异罕见,需进一步研究评估 shelterin 基因变异在甲状腺癌和黑色素瘤中的作用。
研究设计与样本
- 对关键家系行 Sanger 测序筛查 TINF2 突变,并用定量逆转录聚合酶链反应(PCR)分析 TINF2 基因表达。
- 采用外源表达和免疫共沉淀技术评估 TINF2 与 TERF1 的结合。
- 用定量实时 PCR 对淋巴细胞 DNA 定量相对端粒长度(RTL)。
- 对 7 个患 PTC 及其他癌症类型的家系行全外显子测序(WES)。
- 利用 17 个家系的全基因组测序数据和另外 7 个家系的 WES 数据筛查 shelterin 基因 DNA 变异。
主要发现
- TINF2 突变(TINF2 p.Trp198fs)在关键家系中与 PTC 和黑色素瘤完全共分离。
- 该突变未在数据库中报告,也未在筛查的其他 23 个家系中识别。
- 携带突变个体的 TINF2 表达呈临界性降低。
- 截短的 TINF2 蛋白与 TERF1 的结合完全丧失。
- 携带突变个体的 RTL 显著长于同家系非携带者,也显著长于 62 名健康对照。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究评估 shelterin 基因变异在甲状腺癌和黑色素瘤中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Our genome sequencing analysis revealed a frameshift mutation in the shelterin gene TINF2 in a large family with individuals affected with papillary thyroid carcinoma (PTC) and melanoma. Here, we further characterized the mutation and screened for coding variants in the 6 shelterin genes in 24 families. Methods: Sanger sequencing was performed to screen for the TINF2 mutation in the key family. Quantitative reverse transcription-polymerase chain reaction (PCR) was used for TINF2 gene expression analysis. Exogenous expression and co-immunoprecipitation techniques were used for assessing TINF2 binding to TERF1. Relative telomere length (RTL) was quantified in DNAs from lymphocytes by using quantitative real-time PCR. Whole exome sequencing (WES) was performed in seven families with individuals affected with PTC and other cancer types. Screening for DNA variants in shelterin genes was performed by using whole genome sequencing data from 17 families and WES data from 7 further families. Results: The TINF2 mutation (TINF2 p.Trp198fs) showed complete co-segregation with PTC and melanoma in the key family. The mutation is not reported in databases and not identified in 23 other families we screened. The expression of TINF2 was borderline reduced in individuals with the mutation. The truncated TINF2 protein showed abolished binding to TERF1. The RTL in the individuals with the mutation was significantly longer when compared with those without the mutation from the same family as well as compared with 62 healthy controls. Among the 24 families, we identified 3 missense and 1 synonymous variant(s) in 2 shelterin genes (TINF2 and ACD). Conclusions: The rare frameshift mutation in the TINF2 gene and the associated longer telomere length suggest that dysregulated telomeres could be a mechanism predisposing to PTC and melanoma. DNA coding variants in shelterin genes are rare. Further studies are required to evaluate the roles of variants in shelterin genes in thyroid cancer and melanoma.
引用
- He H, Li W, Comiskey DF, et al. A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres. Thyroid. 2020. PMID: 31928178. doi:10.1089/thy.2019.0156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。